Innoviva (INVA) Enterprise Value (2010 - 2026)
Innoviva (INVA) reported Enterprise Value of $1.07 billion for Q2 2026, up 39.4% from $768.16 million a year earlier but down 3.4% from the prior quarter.
Powered by 
Analysis
Innoviva (INVA) Enterprise Value (2010 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Innoviva's Enterprise Value came in at -$641.17 million; for FY2025, it was $925.31 million, up 37.1% from FY2024.
- Enterprise Value has a five-year compound annual growth rate of -3.0% (FY2020 to FY2025).
- By year, Enterprise Value came in at $674.74 million in FY2024 (-17.9%), $821.93 million in FY2023 (+31.4%), $625.69 million in FY2022 (-43.6%) and $1.11 billion in FY2021 (+3.0%).
- Five-year quarterly Enterprise Value spans a low of $596.47 million in Q1 2023 and a high of $1.13 billion in Q1 2022.
- Year over year, Enterprise Value has now increased in each of the last three quarters, with growth averaging 12.9% over the last seven quarters.
- The high point for year-over-year Enterprise Value in five years was Q3 2021 (growth of 77.1%); the low point was Q1 2023 (a decline of 47.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $1.11 billion (Q1 2026), $925.31 million (Q4 2025) and $831.43 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn |
| 10 | Innoviva | 1.54 Bn | -748.67 Mn | 90.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07 Bn |
| Mar 31, 2026 | 1.11 Bn |
| Dec 31, 2025 | 925.31 Mn |
| Sep 30, 2025 | 831.43 Mn |
| Jun 30, 2025 | 768.16 Mn |
| Mar 31, 2025 | 691.16 Mn |
| Dec 31, 2024 | 674.74 Mn |
| Sep 30, 2024 | 948.20 Mn |
| Jun 30, 2024 | 809.01 Mn |
| Mar 31, 2024 | 778.67 Mn |
| Dec 31, 2023 | 821.93 Mn |
| Sep 30, 2023 | 656.35 Mn |
| Jun 30, 2023 | 657.29 Mn |
| Mar 31, 2023 | 596.47 Mn |
| Dec 31, 2022 | 625.69 Mn |
| Sep 30, 2022 | 509.03 Mn |
| Jun 30, 2022 | 745.28 Mn |
| Mar 31, 2022 | 1.13 Bn |
| Dec 31, 2021 | 1.11 Bn |
| Sep 30, 2021 | 1.12 Bn |
API Access
Innoviva Enterprise Value API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=enterprise-value&ticker=INVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "enterprise-value", "ticker": "INVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=enterprise-value&ticker=INVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();